Dinesh Chindarkar |
Facebook, launched in the year 2004, is the most popular social networking website in India with 400 plus million users which makes India #2 in the ranking of all Facebook users by country. Facebook has revolutionised the way people look at and feel about social media. Through this platform people can now stay connected, share photos and information like never before. The usage of Facebook is not restricted only to common people. Celebrities, politicians, sportsmen and also businessmen can exploit Facebook to increase their popularity and social gains. With such perks, how can this media benefit our pharma industry?
With a massive user base, it is definitely a place where the industry can leverage their corporate and/or brand presence through a Facebook page. If you have an OTC brand, you must have a Facebook presence. This may sound compulsive, but in reality, it is compulsory if you want to be seen! People have such easy Internet access these days that social media is the first place they look for further information on any product. A recent study from PWC’s Health Research Institute has established that 40 per cent of consumers have used social media to find health-related brand reviews. As a result, if pharma companies want to earn the attention of modern day consumers, then they need to connect with them through Facebook in order to influence their decisions.
Since pharma brands come under regulations, it is clear that they cannot be advertised. But category building and disease awareness are critical issues that can be addressed using this route. With so much ignorance about health, Facebook opens up a media to reach out to people. Having patient communities on Facebook where one can engage patients, communicate directly with them, share their views and opinions can prove to be an excellent outcome on Facebook for the pharma industry.
Creating a page on Facebook and having a responsible communication for generating disease awareness can indirectly benefit the brand. But before one chooses this path, they ought to be sure that what information they will communicate is what the consumer is really looking for. ‘Psoriasis 360’ was an excellent initiative by J&J that helped connect patients from across the world. They talked about how they felt, shared emotions, problems and crowd sourced solutions too. Learning from each other’s experience they adapted to life better. That was the power of this media in empowering patients.
Company
|
Functionality
|
Likes
|
Pfizer
|
Global comms
|
62744
|
GSK
|
Global comms
|
74113
|
J&J
|
Global comms
|
42833
|
Sanofi US
|
US comms
|
2564
|
Roche
|
Careers
|
12549
|
Abbott
|
Careers
|
27312
|
Boehringer Ingelheim
|
Global comms
|
23366
|
AstraZeneca
|
US comms
|
12226
|
Merck
|
US comms
|
7220
|
*Source: Pharma gets social: World’s top Pharma on Facebook |
Social media listening is the first essential step before one gets on to a Facebook page. Social media listening and web analytics will give you a clearer idea about what people are looking for, what are they talking about and what is the latent need. Social media listening also helps to understand the emotions around a certain issue and the intricacies surrounding it. Based on your research, you can lay down your objective and plan out your strategy.
Apart from creating patient centric Facebook pages, a company can also connect with their customers and stake holders through FB. The few MNC pharma companies who have active Facebook page with large number of engaged users are listed adjacently*
As the healthcare industry is undergoing a rapid change and patients are becoming more tech savvy, even doctors have begun to feel the need to go digital. Doctors in western countries are already using Facebook to share knowledge, retain patients, create awareness, educate about medical inventions, research etc. Gradually this trend has caught up in India as well. A specialised doctor, like a cardiologist or oncologist can create his or her own page and share information about the disease or new treatments and connect with his patients. Especially with the rise in chronic lifestyle disorders, it is changing the way doctor-patient relationship is developing. Even a simple update on water-borne disease trend observed on his FaceBook page by a family physician, helps hundreds of his patients realise the trends and helps in prevention. Community medicine is really turning into ‘community building’ online.
A lot of companies are also considering to build a social model similar to a FaceBook for doctor communities but with a closed platform. So sharing of information within a community of doctors becomes easy and secured. With this there is a personalised engagement with doctors and individual needs could be met. Also it helps understand and profile a doctor based on his behaviour and attitude. With the healthcare industry moving on to the next level where patients have a higher say and control, this is a good time to think about getting a “face” for your brand or company. In this fastest growing network, there is huge opportunity for pharma and it can do lot a more in this growing space.
Industry insights |
Digital Darwinism – the threat is real So, what is at stake, the risk of not being there on the medium where all the relevant conversations are happening or, missing out on the opportunities which the medium presents in terms of efficient reach and experiential engagement with the consumer, who truly and definitely is the centre of the marketing universe. Furthermore, the digital ecosystem, at an evolved level, offers an excellent platform to collaborate for co-creation of value. A good number of companies, across industries, have adapted to this change and have adopted digital marketing practices in a big way, to great advantage. India has been at the forefront of this revolution thanks to the e-penetration rapidly augmented by a phenomenal m-penetration. What about pharma? We are perceived to be slow off the block and rightly so because of the sensitivities and the regulated environment. Social media, being a two-way communication street and a multi-channel environment, obviously need advice and guidelines and it needs to be understood. Of course, the ROI challenge is always there for a new initiative in today’s cost-squeeze business environment. But the question is, can social media forays be now avoided by pharma in India? Increasing number of patients use Internet for health and disease information. Online patient communities are discussing you and your products and lot of experience sharing is happening in real time. If the patients are here, physicians too are on the medium to understand what they want and also to harness the peer-to-peer interaction. Physicians and patients need easy access to the information that they can understand and trust. The onus is on the company to provide the same. A better informed patient who is more likely to adhere to the advice and the therapy also means better health outcomes. This is facilitative of the pay-for-performance model where the payers look at pricing linked to economic benefits. Thus, the social media roadmap goes way beyond product marketing. It facilitates reach, awareness, education, communication and image. This offers the opportunity to build and enhance relationships for the brands at the real and virtual marketplace by integrating the messaging across platforms for maximum impact. While multi-channel marketing may be the starting point, the real gains are in closed-loop marketing where monitoring, tracking and evaluation of the results help in strategic planning addressing expressed needs and wants of stakeholders at each level. For pharma, healthcare is first a responsibility and then an opportunity. The strong emergence and rapid adoption of digital media offers an apt platform for making a difference to the healthcare as well as the brands. Marketing can give information or, source information in real time through the easiest available online web-space thus facilitating the healthcare journey to desired outcomes. Of course, this needs to be done within the prevailing regulations and guidelines. But as Darwin stated, “Survival is ultimately dependent on the ability to change and evolve.” Adapting to the changed reality of the marketplace and adopting newer practices and tools will not only help survive but thrive…..and thrive, successfully. – Amlesh Ranjan, Associate Director, Sanofi *Views expressed are personal |